Pharmacokinetics and the bystander effect in CD::UPRT/5-FC bi-gene therapy of glioma

被引:0
|
作者
SHI Dezhi HU Weixing LI Lixin CHEN Gong WEI Dong GU Peiyuan Department of NeurosurgeryFirst Affiliated Hospital of Nanjing Medical UniversityNanjingJiangsu China [210029 ]
机构
关键词
D O I
暂无
中图分类号
R686 [筋腱、韧带、滑囊疾病及损伤];
学科分类号
1002 ; 100210 ;
摘要
Background Cytosine deaminase (CD) converts 5-fluorocytosine (5-FC) to 5-fluorouracil (5-FU) in CD/5-FC genetherapy,5-FU will be mostly converted into nontoxic β-alanine without uracil phosphoribosyltransferase (UPRT).UPRTcatalyzes the conversion of 5-FU to 5-fluorouridine monophosphate,which directly kills CD::UPRT-expressing cells andsurrounding cells via the bystander effect.But the pharmacokinetics and the bystander effect of CD::UPRT/5-FC has notbeen verified in vivo and in vitro.Before the CD::UPRT/5-FC bi-gene therapy system is used in clinical trial,it is essentialto monitor the transgene expression and function in vivo.Thus,we developed a preclinical tumor model to investigate thefeasibility of usingF-magnetic resonance spectroscopy (F-MRS) and optical imaging to measure non-invasive CDand UPRT expression and its bystander effect.Methods C6 and C6-CD::UPRT cells were cultured with 5-FC.The medium,cells and their mixture were analyzed by19F-MRS.Rats with intracranial xenografted encephalic C6-CD::UPRT glioma were injected intraperitoneally with 5-FCand theirF-MRS spectra recorded.Then the pharmacokinetics of 5-FC was proved.Mixtures of C6 and C6-CD::UPRTcells at different ratios were cultured with 5-FC and the cytotoxic efficacy and survival rate of cells recorded.To determinethe mechanism of the bystander effect,the culture media from cell comprising 25% and 75% C6-CD::UPRT cells wereexamined byF-MRS.A comparative study of mean was performed using analysis of variance (ANOVA).ResultsF-MRS on samples from C6-CD::UPRT cells cultured with 5-FC showed three broad resonance signalscorresponding to 5-FC,5-FU and fluorinated nucleotides (F-Nuctd).For the C6 mixture,only the 5-FC peak was detected.Invivo serialF-MRS spectra showed a strong 5-FC peak and a weak 5-FU peak at 20 minutes after 5-FC injection.The5-FU concentration reached a maximum at about 50 minutes.The F-Nuctd signal appeared after about 1 hour,reached amaximum at around 160 minutes,and was detectable for several hours.At a 10% ratio of C6-CD::UPRT cells,thesurvival rate was (79.55±0.88)% (P <0.01).As the C6-CD::UPRT ratio increased,the survival rate of the cells decreased.F-MRS showed that the signals for 5-FU and F-Nuctd in the culture medium increased as the ratio of C6-CD::UPRT inthe mixture increased.ConclusionsF-MRS studies indicated that C6-CD::UPRT cells could effectively express CD and UPRT enzymes.The CD::UPRT/5-FC system showed an obvious bystander effect.This study demonstrated that CD::UPRT/5-FC genetherapy is suitable for 5-FC to F-Nuctd metabolism; andF-MRS can monitor transferred CD::UPRT gene expressionand catalysis of substrates noninvasively,dynamically and quantitatively.
引用
收藏
页码:1267 / 1272
相关论文
共 48 条
  • [31] SuperCD enables low dose 5-FC application for effective suicide gene therapy in a rat hepatoma model both in vitro and in vivo
    Lemken, ML
    Graepler, F
    Wybranietz, WA
    Schmidt, U
    Smirnow, I
    Gross, CD
    Spiegel, M
    Schenk, A
    Graf, H
    Lauer, UA
    Gregor, M
    Armeanu, S
    Bitzer, M
    Lauer, UM
    MOLECULAR THERAPY, 2004, 9 : S223 - S223
  • [32] Bystander effect-mediated gene therapy of experimental brain tumor by glioma cells carrying HSV-tk gene
    Tagawa, M
    Namba, H
    Iwadate, Y
    Miyagawa, T
    Sakiyama, S
    CANCER GENE THERAPY, 1997, 4 (06) : P119 - P119
  • [33] Vectorized gene therapy of liver tumors: Safety and proof of concept of TG4023 (MVA-FCU1)/5-FC combination
    Husseini, Faress
    Delord, Jean-Pierre
    Fournel-Frederico, Cecile
    Kurtz, Jean-Emmanuel
    Erbs, Philippe
    Homerin, Michel
    Halluard, Celine
    Jemming, Chloe
    Orange, Clelia
    Limacher, Jean-Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [34] A first-in-human study of neural stem cells (NSCs) expressing cytosine deaminase (CD) in combination with 5-fluorocytosine (5-FC) in patients with recurrent high-grade glioma
    Portnow, Jana
    Badie, Behnam
    Synold, Timothy W.
    Annala, Alexander
    Chen, Bihong
    Frank, Joseph
    Moats, Rex A.
    Wood, John
    D'Apuzzo, Massimo
    Bedell, Victoria
    Frankel, Paul Henry
    Aboody, Karen S.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [35] Normal brain cells contribute to the bystander effect in a suicide gene therapy approach for malignant glioma using lentiviral pseudotyped vectors
    Giroglou, Tsanan
    Miletic, Hrvoje
    Fischer, Yvonne
    Rueger, Maria Adele
    Li, Huongfeng
    Himmelreich, Uwe
    Stenzel, Werner
    Jacobs, Andreas H.
    von Laer, Dorothee
    HUMAN GENE THERAPY, 2007, 18 (10) : 1025 - 1025
  • [36] A PHASE I STUDY OF CYTOSINE DEAMINASE-EXPRESSING NEURAL STEM CELLS (CD-NSCs) ADMINISTERED INTRACRANIALLY AND IN COMBINATION WITH ORAL 5-FLUOROCYTOSINE (5-FC) AND LEUCOVORIN IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA
    Portnow, Jana
    Synold, Timothy
    Badie, Behnam
    Blanchard, Suzette
    Kilpatrick, Julie
    Tirughana, Revathiswari
    Metz, Marianne
    Tran, Vivi
    Aboody, Karen
    NEURO-ONCOLOGY, 2018, 20 : 16 - 16
  • [37] Connexin over-expression differentially suppresses glioma growth and contributes to the bystander effect following HSV-thymidine kinase gene therapy
    Jimenez, T
    Fox, WP
    Naus, CCG
    Galipeau, J
    Belliveau, DJ
    CELL COMMUNICATION AND ADHESION, 2006, 13 (1-2): : 79 - 92
  • [38] Bystander effect in uracil phosphoribosyltransferase 5-fluorouracil-mediated suicide gene therapy is correlated with the level of intercellular communication
    Kawamura, K
    Bahar, R
    Namba, H
    Seimiya, M
    Takenaga, K
    Hamada, H
    Sakiyama, S
    Tagawa, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 18 (01) : 117 - 120
  • [39] Local inflammation and devascularization -: in vivo mechanisms of the "bystander effect" in VPC-mediated HSV-Tk/GCV gene therapy for human malignant glioma
    Floeth, FW
    Shand, N
    Bojar, H
    Prisack, HB
    Felsberg, J
    Neuen-Jacob, E
    Aulich, A
    Burger, KJ
    Bock, WJ
    Weber, F
    CANCER GENE THERAPY, 2001, 8 (11) : 843 - 851
  • [40] Local inflammation and devascularization — in vivo mechanisms of the “bystander effect” in VPC-mediated HSV-Tk/GCV gene therapy for human malignant glioma
    Frank W Floeth
    Nick Shand
    Hans Bojar
    Hans B Prisack
    Jörg Felsberg
    Eva Neuen-Jacob
    Albrecht Aulich
    Klaus J Burger
    Wolfgang J Bock
    Friedrich Weber
    Cancer Gene Therapy, 2001, 8 : 843 - 851